オーラルセッション
- 第1日 5月19日（水） 14:30～15:10 B会場（Zoom）
-
1B-O2-1430 PDF
精密医療（プレシジョンメディシン）に向けた包括的統合オミックス解析
The Research and Development Center for Precision Medicine (PMC) was established as Japan’s first omics analysis center aiming to develop a $1000 genome sequencing technology. Using state-of-the-art technologies in Whole Genome Sequencing and Advanced Mass Spectrometry supported by Shimadzu Corporation, the Center aims to provide analytic and translational approaches to provide precise diagnosis of cancers and various diseases in a data-driven/evidence-based approach. The Center has been working with the Tsukuba Preventive Medicine Research Center, which offers a comprehensive medical examination utilizing the function of initiative prevention of medical research. In order to promote collaborations with leading domestic and international research institutions, the PMC is also active in cross-border multidisciplinary networking. The Center aims to establish a research infrastructure for the implementation and realization of Precision Medicine, to improve/determine the best course of treatment for each individual. Furthermore, the spin-off biotech company, iLAC Co., Ltd., mainly focuses on integration of Precision Medicine, Humanoid Type of Robotics and Block Chain, contributing to the 4IR (Fourth Industrial Revolution).